Phase Ib study of plitidepsin (APL) with gemcitabine (GEM) in refractory solid tumors and lymphoma patients.
Mark N. Stein
No relevant relationships to disclose
Vincent Ribrag
No relevant relationships to disclose
Carlos Alberto Gomez-Roca
No relevant relationships to disclose
Gilles A. Salles
No relevant relationships to disclose
Angelo Michele Carella
No relevant relationships to disclose
Emmanuel Gyan
No relevant relationships to disclose
Sergio A. Szyldergemajn
No relevant relationships to disclose
Carmen Maria Kahatt
No relevant relationships to disclose
Manuel Luque
No relevant relationships to disclose
Sonia Extremera
No relevant relationships to disclose
Bernardo De Miguel
No relevant relationships to disclose
Eva Fernandez-Garcia
No relevant relationships to disclose
Jean-Charles Soria
Consultant or Advisory Role - PharmaMar